Intensive chemotherapy can dramatically boost survival of older teenage leukemia patients

    The default player for embedding or displaying video on stjude.org. Default size: 544 x 306


    More effective risk-adjusted chemotherapy and sophisticated patient monitoring helped push cure rates to nearly 88 percent for older adolescents enrolled in a St. Jude Children’s Research Hospital acute lymphoblastic leukemia (ALL) treatment protocol and closed the survival gap between older and younger patients battling the most common childhood cancer.